BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9264714)

  • 1. [Ca-19-9, carcinoembryonic antigen, and alpha-fetoprotein in the serum of nononcological patients and their clinical significance].
    Skvortsov SV; Kushlinskiĭ NE; Kadagidze ZG; Kasumov ChM
    Biull Eksp Biol Med; 1997 May; 123(5):566-9. PubMed ID: 9264714
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
    Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
    Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers in cancer of the digestive system].
    Zinser JW
    Rev Gastroenterol Mex; 1997; 62(3):145-8. PubMed ID: 9480520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cryptates applied in tumor marker assays (CEA, AFP, CA 15.3, CA19.9): evaluation of Kryptor (Cis-Bio) analyser].
    Gherardi C; Roumier AS; Dubucquoi S; Dessaint JP
    Ann Biol Clin (Paris); 1998; 56(1):92-5. PubMed ID: 9754229
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum tumor markers in patients on dialysis and kidney transplantation.
    Lye WC; Tambyah P; Leong SO; Lee EJ
    Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma.
    Uçkaya G; Ozet A; Arpaci A; Kömürcü S
    Nuklearmedizin; 1998; 37(8):297-8. PubMed ID: 9868713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dimorphous cancer of the lung].
    Briusov PG; Leonova VV
    Vopr Onkol; 1997; 43(2):205-7. PubMed ID: 9214124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of 2 tumor markers (alpha-fetoprotein and carcinoembryonic antigen) in the serum by a new immunonephelometric technique].
    Gray H; Sauger F; Maitrot B
    Ann Biol Clin (Paris); 1997; 55(6):597-600. PubMed ID: 9499921
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring].
    Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extragonadal germ cell tumor of mediastinum with high serum level of carcinoembryonic antigen and carbohydrate antigen 19-9.
    Kitsukawa SI; Kin T; Tsukamoto T; Yonese J; Ishikawa Y; Fukui I
    J Urol; 2000 Mar; 163(3):912-3. PubMed ID: 10688012
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
    Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
    J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological variation and reference change values of CA 19-9, CEA, AFP in serum of healthy individuals.
    Erden G; Barazi AO; Tezcan G; Yildirimkaya MM
    Scand J Clin Lab Invest; 2008; 68(3):212-8. PubMed ID: 17926198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A profile of tumor markers in the population of Kuwait.
    al-Sayer H; al-Bader A; Hussein T; Mathew A; Behbehani A; Dashti H; Farghaly M; Khorsheed M; Van Dalen A
    Anticancer Res; 1999; 19(3B):2369-72. PubMed ID: 10472358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of colonoscopy on tumor markers.
    Scapa E; Broide E; Pinhasov I
    Surg Laparosc Endosc; 1997 Dec; 7(6):477-9. PubMed ID: 9438630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
    Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
    Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of tumor markers in gestational trophoblastic diseases.
    Ahmad AE; Dehaghani AS; Shaker M; Fattahi MJ
    J Reprod Med; 2008 Dec; 53(12):930-4. PubMed ID: 19160651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
    Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
    Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of serologic tumor markers in gastrointestinal malignancies.
    Posner MR; Mayer RJ
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):533-53. PubMed ID: 8707771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.